WebJan 12, 2024 · Biophytis SA received a deficiency notice from The Nasdaq Stock Market, Inc. stating that the Company has not filed its financial information for the six-month period ended June 30, 2024 on a Form 6-K and as a result the Company no longer complies with Nasdaq's listing rules for continued listing set forth in the Listing Rule 5250. WebJan 12, 2024 · Biophytis / Key word(s): MiscellaneousBiophytis to take appropriate measures after receiving Nasdaq deficiency notice 12-Jan-2024 / 08:00 CET/CESTBiophytis to take appropriate measures after receiving Nasdaq deficiency notice Paris (France), Cambridge (Massachusetts, U.S.), January 12th, 2024, 8am CET – …
BPTS Short Interest Ratio and Volume (Biophytis) - MarketBeat
WebJan 12, 2024 · Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the ... how many straws of semen for cow
Biophytis Announces Pricing of $20.1 Million U.S. Initial
WebApr 6, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BPTS shares currently have a short interest ratio of 1.0. Learn More on Biophytis's short interest ratio. WebBiophytis. Biophytis is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratoy failure in patients suffering from COVID-19. WebGet the latest Biophytis SA (BPTS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … how many stray cats are in texas